• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form NT 10-Q filed by The Joint Corp.

    8/11/25 7:53:37 PM ET
    $JYNT
    Multi-Sector Companies
    Miscellaneous
    Get the next $JYNT alert in real time by email
    NT 10-Q 1 form12b-25nt10xq.htm FORM NT 10-Q Document











    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    FORM 12b-25

    NOTIFICATION OF LATE FILING

    SEC File Number: 001-36724
    CUSIP Number: 47973J102

    (Check One): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K
    ☒ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR

    For Period Ended: June 30, 2025

    ☐ Transition Report on Form 10-K
    ☐ Transition Report on Form 20-F
    ☐ Transition Report on Form 11-K
    ☐ Transition Report on Form 10-Q

    For the Transition Period Ended:

    Nothing in this Form shall be construed to imply that the Commission has verified any
    information contained herein.

    If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:

    _____________________________________________________________________________________

    PART I – REGISTRANT INFORMATION

    The Joint Corp. ________________________________________________________________________
    Full Name of Registrant

    N/A_________________________________________________________________________________
    Former Name if Applicable

    16767 N. Perimeter Drive, Suite 110_______________________________________________________
    Address of Principal Executive Officer (Street and Number)

    Scottsdale, Arizona 85260_______________________________________________________________
    City, State and Zip Code

    PART II – RULES 12b-25(b) AND (c)
    If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)













    (a)The reason described in reasonable detail in Part III of this Form could not be eliminated without unreasonable effort or expense;
    ☒
    (b)The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-CEN or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and
    (c)The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

    PART III – NARRATIVE

    State below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-CEN, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.

    We have determined that we are unable, without unreasonable effort or expense, to file our Quarterly Report on Form 10-Q for the quarter ended June 30, 2025 (the “Form 10-Q”) with the Securities and Exchange Commission (the “SEC”) within the prescribed time period for the reasons described below.

    On July 30, 2025, we filed a Current Report on Form 8-K with the SEC disclosing that our Chief Financial Officer, following discussions with the members of the Audit Committee of our Board of Directors and in consultation with BDO USA, P.C (“BDO”), our independent registered public accounting firm, concluded that each of (i) our previously issued audited financial statements as of and for the year ended December 31, 2024 included in our Annual Report on Form 10-K for the year ended December 31, 2024 and (ii) our previously issued unaudited interim financial statements included in our Quarterly Report on Form 10-Q for the quarter ended March 31, 2025 (collectively, the “Previously Issued Financial Statements”) contain material errors and should be restated. The identified errors relate to the previously recorded impairment on the carrying values of company-owned or managed clinics classified as held for sale and included in discontinued operations. We are also evaluating the impact of the identified errors on our internal control over financial reporting and disclosure controls and procedures. Although the evaluation is not yet complete, we expect it will result in a material weakness in our internal control over financial reporting and will conclude that our disclosure controls and procedures were ineffective during the applicable periods related to the Previously Issued Financial Statements.

    We are continuing to work diligently, with the assistance of BDO, to determine the degree to which the identified errors will affect our Previously Issued Financial Statements and to restate the Previously Issued Financial Statements, which is necessary for BDO to complete its quarterly review procedures related to the Form 10-Q. We intend to file the Form 10-Q on or before the fifth calendar day following its prescribed due date.

    PART IV – OTHER INFORMATION

    (1)Name and telephone number of person to contact in regard to this notification.

    Scott J. Bowman(205)746-9113
    (Name)(Area Code)(Telephone Number)

    (2)Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or













    for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s). ☒ Yes ☐ No

    (3)Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof? ☒ Yes ☐ No

    If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

    Explanation of the Anticipated Change

    We are currently in the process of, but have not yet completed, our review to determine the degree to which the identified errors will affect our Previously Issued Financial Statements. Based on our preliminary review, we expect the following estimated impact:

    •For the year ended December 31, 2024, the correction for the impairment on assets held for sale is expected to result in a reduction of previously reported loss from discontinued operations before income taxes of approximately $2.2 million. As a result, the total impact of this adjustment for the year is an estimated $2.2 million decrease in net loss for the year ended December 31, 2024 and an estimated $2.2 million increase in the carrying value of assets held for sale reported in discontinued operations current assets for the period then ended. This adjustment is not expected to have any impact on Adjusted EBITDA for the year ended December 31, 2024, nor on cash, cash equivalents, or restricted cash as of that date.

    •For the period ended March 31, 2025, the correction for the impairment on assets held for sale is expected to result in an increase of previously reported income from discontinued operations before income taxes of approximately $0.5 million. As a result, the total impact of these adjustments is an estimated $0.5 million increase in net income for the quarter ended March 31, 2025 and an estimated cumulative $2.7 million increase in the carrying value of assets held for sale reported in discontinued operations current assets for the period then ended. This adjustment is not expected to have any impact on Adjusted EBITDA for the three months ended March 31, 2025, or on cash, cash equivalents, or restricted cash as of that date.

    We intend to file, as soon as practicable, an amended Annual Report on Form 10-K/A and an amended Quarterly Report on Form 10-Q/A, which will contain the restated Previously Issued Financial Statements.

    Forward-Looking Statements

    This Notification of Late Filing on Form 12b-25 contains statements about future events and expectations that constitute forward-looking statements. Forward-looking statements, including expectations about the timing of the completion and filing of the Form 10-Q, Form 10-K/A, and Form 10-Q/A and the anticipated impact and effects of the identified errors on the Previously Issued Financial Statements, are based on our beliefs, assumptions, and expectations of industry trends, our future financial and operating performance, and our growth plans, taking into account the information currently available to us. These statements are not statements of historical fact. Forward-looking statements involve risks and













    uncertainties that may cause our actual results to differ materially from the expectations of future results we express or imply in any forward-looking statements, and you should not place undue reliance on such statements. Factors that could contribute to these differences include, but are not limited to, our inability to identify and recruit enough qualified chiropractors and other personnel to staff our clinics, due in part to the nationwide labor shortage and an increase in operating expenses due to measures we may need to take to address such shortage; inflation, leading to increased labor costs and interest rates, as well as changes to import tariffs, may lead to reduced discretionary spending, all of which may negatively impact our business; our failure to profitably operate company-owned or managed clinics; our failure to refranchise as planned; short-selling strategies and negative opinions posted on the internet, which could drive down the market price of our common stock and result in class action lawsuits; our failure to remediate future material weaknesses in our internal control over financial reporting, which could negatively impact our ability to accurately report our financial results, prevent fraud, or maintain investor confidence; and the factors described in our filings with the SEC, including in the section entitled “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2024 filed with the SEC on March 14, 2025 and subsequent filings with the SEC. Words such as “anticipates,” “believes,” “continues,” “estimates,” “expects,” “goal,” “objectives,” “intends,” “may,” “opportunity,” “plans,” “potential,” “near-term,” “long-term,” “projections,” “assumptions,” “projects,” “guidance,” “forecasts,” “outlook,” “target,” “trends,” “should,” “could,” “would,” “will,” and similar expressions are intended to identify such forward-looking statements. We qualify any forward-looking statements entirely by these cautionary factors. We assume no obligation to update or revise any forward-looking statements for any reason or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. Comparisons of results for current and any prior periods are not intended to express any future trends or indications of future performance, unless expressed as such, and should only be viewed as historical data.





































    The Joint Corp.
    (Name of Registrant as Specified in Charter)

    has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

    Date:8/11/2025By:/s/ Scott J. Bowman
    Scott J. Bowman
    Chief Financial Officer


    Get the next $JYNT alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $JYNT

    DatePrice TargetRatingAnalyst
    9/19/2023$9.00Hold
    Craig Hallum
    8/11/2023Buy → Hold
    Maxim Group
    3/13/2023$12.00 → $15.00Underperform → Neutral
    DA Davidson
    8/5/2022$31.00Neutral → Buy
    B. Riley Securities
    8/5/2022$36.00Hold → Buy
    Maxim Group
    5/9/2022$69.00 → $13.00Neutral → Underperform
    DA Davidson
    5/6/2022$90.00 → $30.00Buy → Hold
    Craig Hallum
    2/25/2022$128.00 → $69.00Buy
    DA Davidson
    More analyst ratings

    $JYNT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Grandpre Christopher M bought $104,082 worth of shares (10,000 units at $10.41), increasing direct ownership by 34% to 39,383 units (SEC Form 4)

    4 - JOINT Corp (0001612630) (Issuer)

    8/22/25 4:52:37 PM ET
    $JYNT
    Multi-Sector Companies
    Miscellaneous

    Director Grandpre Christopher M bought $263,509 worth of shares (24,388 units at $10.80), increasing direct ownership by 488% to 29,383 units (SEC Form 4)

    4 - JOINT Corp (0001612630) (Issuer)

    8/19/25 5:33:07 PM ET
    $JYNT
    Multi-Sector Companies
    Miscellaneous

    Director Grandpre Christopher M was granted 4,995 shares (SEC Form 4)

    4 - JOINT Corp (0001612630) (Issuer)

    7/23/25 4:48:46 PM ET
    $JYNT
    Multi-Sector Companies
    Miscellaneous

    $JYNT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    The Joint Corp. to Host Conference Call on Thursday, August 7th to Discuss Second Quarter 2025 Results

    SCOTTSDALE, Ariz., July 24, 2025 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ:JYNT) the nation's largest franchisor of chiropractic care through The Joint Chiropractic® network, announced it will report its second quarter 2025 financial results on Thursday, August 7, 2025, after the market close. President and CEO Sanjiv Razdan and CFO Scott Bowman will hold a conference call at 5:00 p.m. EDT that day to discuss the results. Shareholders and interested participants may listen to a live broadcast of the conference call by dialing (833) 630-0823 or (412) 317-1831 and ask to be joined into the ‘The Joint' call approximately 15 minutes prior to the start time. The live webcast of the call wi

    7/24/25 7:05:00 AM ET
    $JYNT
    Multi-Sector Companies
    Miscellaneous

    The Joint Chiropractic Launches Official Mobile App on iOS and Android

    – New App Brings Convenient Features to Patients – SCOTTSDALE, Ariz., July 1, 2025 /PRNewswire/ -- Today, The Joint Corp. (NASDAQ:JYNT), the nation's largest franchisor of chiropractic care through The Joint Chiropractic® network, announces the launch of its new mobile app, now available for download in the Apple App Store and Google Play. "Our patients are the center of our mission. The launch of the new mobile app supports that commitment," said Razdan.Created to enhance patient convenience and connectivity, the mobile app introduces a suite of features designed to simplify

    7/1/25 8:47:00 AM ET
    $JYNT
    Multi-Sector Companies
    Miscellaneous

    The Joint Corp. Announces Christopher M. Grandpre Elected as Director

    SCOTTSDALE, Ariz., May 22, 2025 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ:JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic® network dedicated to revolutionizing access to chiropractic care and building a leading wellness franchise with a strong business model, announced Christopher M. Grandpre has been elected as a director to help enable the company in achieving its goals of long-term growth in net new clinic openings, system-wide sales, comparable sales, and Adjusted EBITDA. Lead Director Matthew E. Rubel stated, "Chris is a stellar board member and franchise expert. As Chairman of Empower Brands, he has worked with the executive team to continu

    5/22/25 7:05:00 AM ET
    $JYNT
    Multi-Sector Companies
    Miscellaneous

    $JYNT
    SEC Filings

    View All

    The Joint Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Leadership Update, Financial Statements and Exhibits

    8-K - JOINT Corp (0001612630) (Filer)

    8/27/25 4:06:27 PM ET
    $JYNT
    Multi-Sector Companies
    Miscellaneous

    Amendment: SEC Form SCHEDULE 13G/A filed by The Joint Corp.

    SCHEDULE 13G/A - JOINT Corp (0001612630) (Subject)

    8/21/25 4:18:34 PM ET
    $JYNT
    Multi-Sector Companies
    Miscellaneous

    SEC Form 10-Q filed by The Joint Corp.

    10-Q - JOINT Corp (0001612630) (Filer)

    8/11/25 8:40:44 PM ET
    $JYNT
    Multi-Sector Companies
    Miscellaneous

    $JYNT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Craig Hallum resumed coverage on Joint Corp with a new price target

    Craig Hallum resumed coverage of Joint Corp with a rating of Hold and set a new price target of $9.00

    9/19/23 9:01:50 AM ET
    $JYNT
    Multi-Sector Companies
    Miscellaneous

    Joint Corp downgraded by Maxim Group

    Maxim Group downgraded Joint Corp from Buy to Hold

    8/11/23 9:04:03 AM ET
    $JYNT
    Multi-Sector Companies
    Miscellaneous

    Joint Corp upgraded by DA Davidson with a new price target

    DA Davidson upgraded Joint Corp from Underperform to Neutral and set a new price target of $15.00 from $12.00 previously

    3/13/23 7:31:52 AM ET
    $JYNT
    Multi-Sector Companies
    Miscellaneous

    $JYNT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Grandpre Christopher M bought $104,082 worth of shares (10,000 units at $10.41), increasing direct ownership by 34% to 39,383 units (SEC Form 4)

    4 - JOINT Corp (0001612630) (Issuer)

    8/22/25 4:52:37 PM ET
    $JYNT
    Multi-Sector Companies
    Miscellaneous

    Director Grandpre Christopher M bought $263,509 worth of shares (24,388 units at $10.80), increasing direct ownership by 488% to 29,383 units (SEC Form 4)

    4 - JOINT Corp (0001612630) (Issuer)

    8/19/25 5:33:07 PM ET
    $JYNT
    Multi-Sector Companies
    Miscellaneous

    SEC Form 4: Bandera Partners Llc bought $2,308,155 worth of shares (240,862 units at $9.58)

    4 - JOINT Corp (0001612630) (Issuer)

    9/21/23 5:15:20 PM ET
    $JYNT
    Multi-Sector Companies
    Miscellaneous

    $JYNT
    Leadership Updates

    Live Leadership Updates

    View All

    The Joint Corp. Strengthens Management Appointing SVP Legal and SVP Operations and Patient Experience

    - Franchising legal specialist Andra J. Terrell with 20 years of experience in global master, single-unit and multi-unit franchising; compliance strategy; and financing, mergers, acquisitions, and divestitures- - Franchise operations leader Eric Wyatt with over 30 years of experience to improve clinic economics, enhance the patient experience, and reignite growth – SCOTTSDALE, Ariz., May 06, 2025 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ:JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic® network, welcomes new executives to help execute plan to strengthen the company core, reignite growth, and improve clinic and company level profitability. Both wi

    5/6/25 7:05:00 AM ET
    $JYNT
    Multi-Sector Companies
    Miscellaneous

    The Joint Corp. Names SVP Development

    SCOTTSDALE, Ariz., March 11, 2025 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ:JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic® network, welcomes Craig Sherwood as the company's new Senior Vice President of Development. He will report to President and CEO Sanjiv Razdan. "Craig is a highly accomplished franchise development leader with over 25 years of experience driving strategic growth for brands in the health and wellness and quick-service restaurant industries, including Lumin Fitness, Wingstop, Little Caesars, Gold's Gym, and Sonic," said Razdan. "An exceptionally skilled business leader, attorney, and former Army officer with extensive execut

    3/11/25 7:05:00 AM ET
    $JYNT
    Multi-Sector Companies
    Miscellaneous

    The Joint Chiropractic is Named the Official Chiropractor of Grand Canyon University Athletics

    SCOTTSDALE, Ariz., Oct. 29, 2024 /PRNewswire/ -- The Joint Corp. (NASDAQ:JYNT), the nation's largest franchisor of chiropractic care through The Joint Chiropractic® network, announces its newest sponsorship agreement with Grand Canyon University Athletics. The brand has been named the Official Chiropractor of Grand Canyon University Athletics for a two-year term through 2026. "We are honored to join Lope Country and support the student athletes of Grand Canyon University through our partnership," said Sanjiv Razdan, president and CEO of The Joint Corp. "This sponsorship demons

    10/29/24 8:50:00 AM ET
    $JYNT
    Multi-Sector Companies
    Miscellaneous

    $JYNT
    Financials

    Live finance-specific insights

    View All

    The Joint Corp. to Host Conference Call on Thursday, August 7th to Discuss Second Quarter 2025 Results

    SCOTTSDALE, Ariz., July 24, 2025 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ:JYNT) the nation's largest franchisor of chiropractic care through The Joint Chiropractic® network, announced it will report its second quarter 2025 financial results on Thursday, August 7, 2025, after the market close. President and CEO Sanjiv Razdan and CFO Scott Bowman will hold a conference call at 5:00 p.m. EDT that day to discuss the results. Shareholders and interested participants may listen to a live broadcast of the conference call by dialing (833) 630-0823 or (412) 317-1831 and ask to be joined into the ‘The Joint' call approximately 15 minutes prior to the start time. The live webcast of the call wi

    7/24/25 7:05:00 AM ET
    $JYNT
    Multi-Sector Companies
    Miscellaneous

    The Joint Corp. to Host Conference Call on Thursday, May 8th to Discuss First Quarter 2025 Results

    SCOTTSDALE, Ariz., April 24, 2025 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ:JYNT) a national operator, manager, and franchisor of chiropractic clinics, announced it will report its first quarter 2025 financial results on Thursday, May 8, 2025, after the market close. President and CEO Sanjiv Razdan and CFO Jake Singleton will hold a conference call at 5:00 p.m. EDT that day to discuss the results. Shareholders and interested participants may listen to a live broadcast of the conference call by dialing (833) 630-0823 or (412) 317-1831 and ask to be joined into the ‘The Joint' call approximately 15 minutes prior to the start time. The live webcast of the call with accompanying slide pre

    4/24/25 7:05:00 AM ET
    $JYNT
    Multi-Sector Companies
    Miscellaneous

    The Joint Corp. to Host Conference Call on Thursday, March 13th to Discuss Fourth Quarter and Year-end 2024 Results

    SCOTTSDALE, Ariz., Feb. 20, 2025 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ:JYNT) a national operator, manager, and franchisor of chiropractic clinics, announced it will report its fourth quarter and year-end 2024 financial results on Thursday, March 13, 2025, after the market close. President and CEO Sanjiv Razdan and CFO Jake Singleton will hold a conference call at 5:00 p.m. EST that day to discuss the results. Shareholders and interested participants may listen to a live broadcast of the conference call by dialing (833) 630-0823 or (412) 317-1831 and ask to be joined into the ‘The Joint' call approximately 15 minutes prior to the start time. The live webcast of the call with accomp

    2/20/25 7:05:00 AM ET
    $JYNT
    Multi-Sector Companies
    Miscellaneous

    $JYNT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by The Joint Corp. (Amendment)

    SC 13G/A - JOINT Corp (0001612630) (Subject)

    2/13/24 5:08:04 PM ET
    $JYNT
    Multi-Sector Companies
    Miscellaneous

    SEC Form SC 13G/A filed by The Joint Corp. (Amendment)

    SC 13G/A - JOINT Corp (0001612630) (Subject)

    1/26/24 5:25:22 PM ET
    $JYNT
    Multi-Sector Companies
    Miscellaneous

    SEC Form SC 13G/A filed by The Joint Corp. (Amendment)

    SC 13G/A - JOINT Corp (0001612630) (Subject)

    1/12/24 4:12:38 PM ET
    $JYNT
    Multi-Sector Companies
    Miscellaneous